Ads
related to: autoimmune grafting without bone meal- cGVHD Manifestations
Impacts of Inflammation &
Fibrosis. Learn More Today.
- HCP and Patient Resources
Helpful Resources. Education
and Support. cGVHD Patient Stories.
- Clinical Study Data
Real-World Demographic of Patients.
See Results From a Pivotal Trial.
- Safety Profile
Review Safety Data
From the Clinical Trials.
- cGVHD Manifestations
Search results
Results From The WOW.Com Content Network
In orthopaedic medicine, a bone graft can be sourced from a patient's own bone in order to fill space and produce an osteogenic response in a bone defect. However, due to the donor-site morbidity associated with autograft, other methods such as bone allograft and bone morphogenetic proteins and synthetic graft materials are often used as alternatives.
This field could revolutionize tissue transplants by synthesizing personalized grafts for enhanced integration without immune rejection and reducing reliance on donors. [ 33 ] A diagram of stem cell differentiation, showing the potential of stem cells in creating personalised tissues of various body parts for transplantation.
This article provides a list of autoimmune diseases. These conditions, where the body's immune system mistakenly attacks its own cells, affect a range of organs and systems within the body. Each disorder is listed with the primary organ or body part that it affects and the associated autoantibodies that are typically found in people diagnosed ...
Fibrodysplasia ossificans progressiva (/ ˌ f aɪ b r oʊ d ɪ ˈ s p l eɪ ʒ (i) ə ɒ ˈ s ɪ f ɪ k æ n z p r ə ˈ ɡ r ɛ s ɪ v ə /; [1] abbr. FOP), also called Münchmeyer disease or formerly myositis ossificans progressiva, is an extremely rare connective tissue disease in which fibrous connective tissue such as muscle, tendons, and ligaments turn into bone tissue (ossification).
It is used to treat symptomatic, full-thickness cartilage defects of the knee with or without bone involvement. [2] [1] Autologous cultured chondrocytes on porcine collagen membrane is an autologous cellularized scaffold product. [1] This treatment is approved by the US Food and Drug Administration (FDA). [1] It is only administered to adults. [1]
Graft-versus-host disease (GvHD) is an inflammatory disease that is unique to allogeneic transplantation. It is an attack by the "new" bone marrow's immune cells against the recipient's tissues. This can occur even if the donor and recipient are HLA-identical because the immune system can still recognize other differences between their tissues.
Bone marrow transplant can replace the transplant recipient's immune system with the donor's, and the recipient accepts the new organ without rejection. The marrow's hematopoietic stem cells —the reservoir of stem cells replenishing exhausted blood cells including white blood cells forming the immune system—must be of the individual who ...
Autoimmune diseases predominantly begin in adulthood, although they can start at any age. [1] The initial recognition of autoimmune diseases dates back to the early 1900s, and since then, advancements in understanding and management of these conditions have been substantial, though much more is needed to fully unravel their complex etiology and ...